Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Neoplasm
100%
Pancreas Cancer
61%
Hepatocellular Carcinoma
61%
Recurrent Disease
61%
Gallbladder Cancer
61%
Candidemia
61%
Retrospective Cohort Study
61%
Surgery
53%
Liquid Biopsy
51%
Stomach Cancer
30%
Immunosuppressant
30%
Bile
30%
Radiofrequency Ablation
30%
Endoscopic Submucosal Dissection
30%
COVID-19
30%
Cholecystectomy
30%
Congenital Malformation
30%
Yoga
30%
Telomerase Reverse Transcriptase
30%
Molecular Diagnosis
30%
Hypopharyngeal Cancer
30%
Pancreatic Duct
30%
Mucinous Carcinoma
30%
Endoscopic Ultrasound Guided Fine Needle Biopsy
30%
Capillary Hemangioma
30%
Methylation
30%
Stomach Volvulus
30%
Transcatheter Arterial Chemoembolization
30%
Intervention Study
30%
Electrocoagulation
30%
Disease Free Survival
30%
Gene Promoter
30%
Glucan
30%
Propensity Score Matching
30%
Promoter Region
29%
Endophthalmitis
27%
Circulating Tumor DNA
24%
Droplet Digital Polymerase Chain Reaction
24%
Hazard Ratio
23%
Pancreas Adenocarcinoma
22%
Capillary
22%
Antifungal Therapy
22%
Pancreatic Ductal Adenocarcinoma
21%
Papilloma
20%
Endoscopic Ultrasound
20%
Fine-Needle Aspiration
17%
Multivariate Analysis
15%
Progression Free Survival
15%
Overall Survival
15%
Empathy
15%
Keyphrases
KRAS mutation
61%
Bundle Compliance
51%
Pancreatic Cancer
43%
Liquid Biopsy
35%
Sodium Phosphate Tablets
30%
Serum DNA
30%
Intermediate-stage Hepatocellular Carcinoma
30%
Cystic Malformation
30%
Combination Therapy
30%
Bile
30%
Molecular Diagnostics
30%
Intraductal Papillary mucinous Carcinoma
30%
Sustained Virological Response
30%
Chronic Hepatitis C Infection
30%
Pancreatic Cancer Tissue
30%
Fever Syndromes
30%
Pegylated Interferon
30%
Ribavirin
30%
Endoscopic Ultrasound-guided Fine-needle Aspiration (EUS-FNA)
30%
Acinar-to-ductal Metaplasia
30%
Local Recurrence
30%
Mutation Analysis
30%
Interferon alpha-2b
30%
Gastric Volvulus
30%
Branched-chain Amino Acid Granules
30%
Long-term Supplementation
30%
Gemcitabine-refractory
30%
Radiofrequency Thermocoagulation
30%
MicroRNA-451
30%
Elderly Patients
30%
Gallbladder Cancer
30%
DCC Gene
30%
Self-compassion
30%
Mindfulness Program
30%
Promoter mutation
30%
Care Bundle
30%
Multicenter Retrospective Cohort Study
30%
Propensity Score Analysis
30%
Candida
30%
Candidemia
30%
Telomerase Reverse Transcriptase Promoter mutation
22%
Confidence Interval
21%
G12D
20%
Droplet Digital PCR (ddPCR)
20%
PDAC Cells
18%
Hazard Ratio
18%
Circulating Tumor DNA (ctDNA)
17%
G12V
16%
Odds Ratio
15%
Bowel Cleansing
15%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
99%
Pancreas Cancer
91%
Pancreas Adenocarcinoma
70%
Hepatitis C Virus
61%
Overall Survival
46%
Neoplasm
39%
Lipopolysaccharide
34%
Chemotherapy
33%
Immunosuppressive Agent
30%
Macrogol
30%
Sodium Dihydrogen Phosphate
30%
Peginterferon Alpha2b
30%
Combination Therapy
30%
Infection
30%
Creatinine
30%
Recurrent Disease
30%
Branched Chain Amino Acid
30%
Ribavirin
30%
Chronic Hepatitis C
30%
Syndrome
30%
Cytokine
30%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
30%
Metaplasia
30%
Tablet
30%
microRNA 34a
30%
Gallbladder Cancer
30%
Malignant Neoplasm
29%
Tolerability
25%
Recurrence Free Survival
23%
Survival Rate
18%
Disease Free Survival
15%
Progression Free Survival
15%
Serum Albumin
13%
Adverse Event
12%
Liver Cancer
10%
Mammalian Target of Rapamycin
9%
Phosphatidylinositol 3 Kinase
9%
Injury
7%
Epileptic Absence
7%
Gemcitabine
7%
Fluorouracil
7%
Chronic Hepatitis
7%
Folinic Acid
7%
Biological Marker
7%
Circulating Tumor DNA
7%
Interferon
7%
Paclitaxel
7%
Irinotecan
7%
Oxaliplatin
7%
Hepatitis C
7%